Country: United States
Language: English
Source: NLM (National Library of Medicine)
PROBENECID (UNII: PO572Z7917) (PROBENECID - UNII:PO572Z7917), COLCHICINE (UNII: SML2Y3J35T) (COLCHICINE - UNII:SML2Y3J35T)
Actavis Pharma, Inc.
PROBENECID
PROBENECID 500 mg
ORAL
PRESCRIPTION DRUG
For the treatment of chronic gouty arthritis when complicated by frequent, recurrent acute attacks of gout. Hypersensitivity to this product or to probenecid or colchicine. Probenecid and colchicine tablets are contraindicated in children under 2 years of age. Not recommended in persons with known blood dyscrasias or uric acid kidney stones. Therapy with probenecid and colchicine should not be started until an acute gouty attack has subsided. Probenecid crosses the placental barrier and appears in cord blood. Colchicine can arrest cell division in animals and plants. In certain species of animals under certain conditions, colchicine has produced teratogenic effects. The possibility of such effects in humans also has been reported. Because of the colchicine component, probenecid and colchicine is contraindicated in pregnant patients. The use of any drug in women of childbearing potential requires that the anticipated benefit be weighed against the possible hazards.
Probenecid and Colchicine Tablets USP 500 mg-0.5 mg are bisected, white, capsule-shaped tablets imprinted DAN DAN and 5325 supplied in bottles of 100. Dispense in a well closed, light-resistant container with child-resistant closure. Store at 20 - 25°C (68 - 77°F). [See USP controlled room temperature.] Protect from light. Manufactured by: Watson Pharma Private Ltd. Verna, Salcette Goa 403 722 INDIA Distributed by: Actavis Pharma, Inc. Parsippany, NJ 07054 USA Revised: December 2016
Abbreviated New Drug Application
PROBENECID AND COLCHICINE- PROBENECID AND COLCHICINE TABLET ACTAVIS PHARMA, INC. ---------- PROBENECID AND COLCHICINE TABLETS USP REVISED: DECEMBER 2016 RX ONLY 190813-1 DESCRIPTION Probenecid and colchicine contains probenecid, which is a uricosuric agent, and colchicine, which has antigout activity, the mechanism of which is unknown. Probenecid is the generic name for 4-[(dipropylamino)sulfonyl] benzoic acid. The structural formula is represented below: C H NO S M.W. 285.36 Probenecid is a white or nearly white, fine, crystalline powder. It is soluble in dilute alkali, in alcohol, in chloroform, and in acetone; it is practically insoluble in water and in dilute acids. Colchicine is an alkaloid obtained from various species of Colchicum. The chemical name for colchicine is (_S_)-_N_-(5,6,7,9- tetrahydro-1,2,3,10-tetramethoxy-9- oxobenzo[_α_]heptalen-7-yl) acetamide. The structural formula is represented below: C H NO M.W. 399.44 Colchicine consists of pale yellow scales or powder; it darkens on exposure to light. Colchicine is soluble in water, freely soluble in alcohol and in chloroform, and slightly soluble in ether. 13 19 4 22 25 6 Each tablet for oral administration contains 500 mg of probenecid and 0.5 mg of colchicine. Each tablet also contains the following inactive ingredients: colloidal silicon dioxide, magnesium stearate, microcrystalline cellulose, sodium lauryl sulfate and sodium starch glycolate. CLINICAL PHARMACOLOGY Probenecid is a uricosuric and renal tubular blocking agent. It inhibits the tubular reabsorption of urate, thus increasing the urinary excretion of uric acid and decreasing serum urate levels. Effective uricosuria reduces the miscible urate pool, retards urate deposition, and promotes resorption of urate deposits. Probenecid inhibits the tubular secretion of penicillin and usually increases penicillin plasma levels by any route the antibiotic is given. A 2-fold to 4-fold elevation has been demonstrated for various penicillins. P Read the complete document